Sort
39,280 grants matching “leukemia”
Genetics and Bioinformatics Core Laboratory
$2,627,287Daniel Weinberger · National Institute Of Mental Health · ZIC · FY2011 · MH
Genotyping for epidemiology studies
$2,623,215David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
Bone Marrow Grafting for Leukemia and Lymphoma
$2,619,001Robert S Negrin · Stanford University · P01 · FY2014 · CA
Genomics of Acute Myelogenous Leukemia
$2,618,366Washington University · P01 · FY2003 · CA
NEXT GENERATION DNMT1 DEPLETION THERAPY FOR LEUKEMIA
$2,617,431The Cleveland Clinic Foundation · · FY2009 · Department of Defense
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,612,197Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2016 · CA
Systems Biology of In Vivo Human Blood Cell Populations
$2,611,250John Matthew Higgins · Massachusetts General Hospital · DP2 · FY2012 · DK
Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders
$2,610,373Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders
$2,609,499Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Administrative Core
$2,603,385Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2020 · CA
ECOG-ACRIN Biorepositories to Support NCTN
$2,602,733Ignacio I. Wistuba · Ecog-Acrin Medical Research Foundation · U24 · FY2017 · CA
University of Virginia Cancer Center Support Grant
$2,602,707Thomas P Loughran · University Of Virginia · P30 · FY2023 · CA
University of Virginia Cancer Center Support Grant
$2,602,707Thomas P Loughran · University Of Virginia · P30 · FY2025 · CA
University of Virginia Cancer Center Support Grant
$2,602,707Thomas P Loughran · University Of Virginia · P30 · FY2022 · CA
University of Virginia Cancer Center Support Grant
$2,602,707Thomas P Loughran · University Of Virginia · P30 · FY2024 · CA
p53, Aging, and Cancer
$2,600,582Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Studies of Occupational Cancer
$2,599,567Qing Lan · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease
$2,599,447Huntington Potter · University Of Colorado Denver · R01 · FY2023 · AG
Advancing the Lives & HeaLth of Youth and Young Adults with Down Syndrome (ALLY-DS)
$2,598,199Andrea Bridget Kelly · Children'S Hosp Of Philadelphia · U01 · FY2024 · HD
Impacts of Genetic and Environmental Factors on Reproductive Organ Development
$2,596,925Hung Chang Yao · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Down Syndrome as a systemic autophagy deficiency disorder
$2,594,673James V Degregori · University Of Colorado Denver · R01 · FY2020 · HD
Center for pediatric tumor cell atlas
$2,593,508Kai Tan · Children'S Hosp Of Philadelphia · U2C · FY2019 · CA
Center for the Spatiotemporal Modeling of Cell Signaling (STMC)
$2,593,428Bridget S Wilson · University Of New Mexico Health Scis Ctr · P50 · FY2013 · GM
A novel glycan-based selectin and complement inhibitor for at-home disease-modifying rescue of pain crisis in sickle cell disease
$2,589,070John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc. · UG3 · FY2023 · NS
BONE MARROW GRAFTING FOR LEUKEMIA AND LYMPHOMA
$2,582,252Stanford University · P01 · FY2001 · CA